{"database": "lobbying", "table": "lobbying_activities", "rows": [[2911166, "e528d1ef-e0d0-41c5-b93a-42d2ab2e2696", "Q4", "MARSHALL & POPP, LLC", 401105121, "BUTTERFLY NETWORK, INC.", 2022, "fourth_quarter", "SCI", "Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act, and H.R.2617, Consolidated Appropriations Act, 2023. Issues related to FDA regulation of medical devices, including including S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R.6833, Making continuing appropriations for fiscal year 2023, and H.R.2617, Consolidated Appropriations Act, 2023.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2023-01-14T15:16:59-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2911166"], "units": {}, "query_ms": 0.741788069717586, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}